Elevating the patient’s voice: Servier Hellas’s commitment to oncology
All the news from Servier Group
Servier takes on therapeutic adherence!
Finally, a day dedicated to therapeutic adherence!
Unveiling of a new production unit in France
Open innovation: 3 Compelling Reasons to choose a Public-Private Partnership in Healthcare
Life after cancer: learning to live differently, a challenge for survivors
Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
Servier is awarded the Gallup Exceptional Workplace Award for the second consecutive year
Servier’s 2023-2024 Annual Integrated Report is now available!